AMOEBA SAS (ALMIB.PA) Fundamental Analysis & Valuation

EPA:ALMIB • FR0011051598

Current stock price

0.873 EUR
+0.01 (+1.28%)
Last:

This ALMIB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALMIB.PA Profitability Analysis

1.1 Basic Checks

  • ALMIB had negative earnings in the past year.
  • ALMIB had a negative operating cash flow in the past year.
  • In the past 5 years ALMIB always reported negative net income.
  • In the past 5 years ALMIB always reported negative operating cash flow.
ALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M

1.2 Ratios

  • ALMIB has a worse Return On Assets (-81.95%) than 92.75% of its industry peers.
Industry RankSector Rank
ROA -81.95%
ROE N/A
ROIC N/A
ROA(3y)-142.01%
ROA(5y)-108.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMIB.PA Yearly ROA, ROE, ROICALMIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K -2K 4K

1.3 Margins

  • ALMIB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMIB.PA Yearly Profit, Operating, Gross MarginsALMIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ALMIB.PA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, ALMIB has more shares outstanding
  • The number of shares outstanding for ALMIB has been increased compared to 5 years ago.
  • ALMIB has a better debt/assets ratio than last year.
ALMIB.PA Yearly Shares OutstandingALMIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ALMIB.PA Yearly Total Debt VS Total AssetsALMIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • ALMIB has an Altman-Z score of -4.09. This is a bad value and indicates that ALMIB is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -4.09, ALMIB is not doing good in the industry: 88.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.09
ROIC/WACCN/A
WACCN/A
ALMIB.PA Yearly LT Debt VS Equity VS FCFALMIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that ALMIB may have some problems paying its short term obligations.
  • ALMIB's Current ratio of 0.98 is on the low side compared to the rest of the industry. ALMIB is outperformed by 85.51% of its industry peers.
  • A Quick Ratio of 0.90 indicates that ALMIB may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.90, ALMIB is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.9
ALMIB.PA Yearly Current Assets VS Current LiabilitesALMIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALMIB.PA Growth Analysis

3.1 Past

  • The earnings per share for ALMIB have decreased by -8.28% in the last year.
EPS 1Y (TTM)-8.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ALMIB will show a very strong growth in Earnings Per Share. The EPS will grow by 40.69% on average per year.
  • ALMIB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 186.76% yearly.
EPS Next Y-7.14%
EPS Next 2Y32.14%
EPS Next 3Y43.46%
EPS Next 5Y40.69%
Revenue Next Year963.63%
Revenue Next 2Y517.91%
Revenue Next 3Y359.4%
Revenue Next 5Y186.76%

3.3 Evolution

ALMIB.PA Yearly Revenue VS EstimatesALMIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
ALMIB.PA Yearly EPS VS EstimatesALMIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALMIB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALMIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMIB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMIB.PA Price Earnings VS Forward Price EarningsALMIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMIB.PA Per share dataALMIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALMIB's earnings are expected to grow with 43.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.14%
EPS Next 3Y43.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALMIB.PA Dividend Analysis

5.1 Amount

  • ALMIB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMIB.PA Fundamentals: All Metrics, Ratios and Statistics

AMOEBA SAS

EPA:ALMIB (4/23/2026, 7:00:00 PM)

0.873

+0.01 (+1.28%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-23
Earnings (Next)N/A
Inst Owners0.36%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap67.94M
Revenue(TTM)N/A
Net Income(TTM)-8.30M
Analysts85.45
Price Target1.53 (75.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -81.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-142.01%
ROA(5y)-108.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 138.84%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.9
Altman-Z -4.09
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)326.73%
Cap/Depr(5y)204.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.29%
EPS Next Y-7.14%
EPS Next 2Y32.14%
EPS Next 3Y43.46%
EPS Next 5Y40.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year963.63%
Revenue Next 2Y517.91%
Revenue Next 3Y359.4%
Revenue Next 5Y186.76%
EBIT growth 1Y-19.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.71%
EBIT Next 3Y55.71%
EBIT Next 5YN/A
FCF growth 1Y-17.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.45%
OCF growth 3YN/A
OCF growth 5YN/A

AMOEBA SAS / ALMIB.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AMOEBA SAS?

ChartMill assigns a fundamental rating of 1 / 10 to ALMIB.PA.


What is the valuation status for ALMIB stock?

ChartMill assigns a valuation rating of 1 / 10 to AMOEBA SAS (ALMIB.PA). This can be considered as Overvalued.


How profitable is AMOEBA SAS (ALMIB.PA) stock?

AMOEBA SAS (ALMIB.PA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for AMOEBA SAS?

The Earnings per Share (EPS) of AMOEBA SAS (ALMIB.PA) is expected to decline by -7.14% in the next year.